Svirsky, Howard, and Berman have enumerated a variety of U.S. FDA roles, arguing that although the public possess a “right to information” about health risks,...

In the target article by Kolbe and de Melo-Martin (2023), the authors discussed several shortcomings of major instruments of moral distress, including the Moral Distress Scale (MDS) (Corley et al....

The target article by Lynch et al. offers approaches for improving trial availability and Expanded Access for non-pandemic diseases based on the analysis of the COVID-19 experience in the US...